• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas

  • Respiratory/Inflammation

The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials.  For more information on both of these therapy areas please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • expand The asthma control rate achieved by budesonide/formoterol in clinical practice in China
    Study Id
    NIS-RCN-SYM-2012/1
    Disease
    asthma
    Drug Name
    non drug study (respiratory)
    Study Name
    NIS-RCN-SYM-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Oxis 9mcg Turbuhaler Clinical Experience Investigation
    Study Id
    D5127L00001
    Disease
    chronic obstructive pulmonary disease
    Drug Name
    Oxis Turbuhaler
    Study Name
    D5127L00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Perception of symptom variability in Chinese COPD patients
    Study Id
    NIS-RCN-XXX-2012/1
    Disease
    chronic obstructive pulmonary disease
    Drug Name
    non drug study (respiratory)
    Study Name
    NIS-RCN-XXX-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Clinical Experience Investigation for treatment with Symbicort as maintenance therapy and as needed in response to symptoms
    Study Id
    D589LL00001
    Disease
    asthma
    Drug Name
    Symbicort Turbuhaler
    Study Name
    D589LL00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Symbicort Turbulaler 30/60 Special Clinical Experince Investigation for long-term use for COPD patients
    Study Id
    D589DL00001
    Disease
    chronic obstructive pulmonary disease
    Drug Name
    Symbicort Turbuhaler
    Study Name
    D589DL00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase 2, Open-Label Extension Study to Evaluate Long-Term Safety of MEDI-546 in Adults with Systemic Lupus Erythematosus
    Study Id
    CD-IA-MEDI-546-1145
    Disease
    systemic lupus erthematosus
    Drug Name
    MEDI-546
    Study Name
    CD-IA-MEDI-546-1145
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A 6-month, Randomised, Double-blind, Placebo-controlled, Multi-centre, Parallel-group, Phase II Study with an Optional Safety Extension Treatment Period up to 6 months, to Evaluate the Efficacy, Safety, and Tolerability of 3 Different Doses of AZD5069 Twice Daily as Add-on Treatment to Medium to High Dose Inhaled Corticosteroids (ICS) and Long-acting β2 Agonists (LABA), in Patients with Uncontrolled Persistent Asthma
    Study Id
    D3551C00001
    Disease
    asthma
    Drug Name
    AZD5069
    Study Name
    D3551C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand An Observational Study to Assess Respiratory Syncytial Virus (RSV)-Associated Illness in Adults with Chronic Obstructive Pulmonary Disease (COPD) and/or Congestive Heart Failure (CHF)
    Study Id
    CD-ID-MEDI-557-1089
    Disease
    chronic obstructive pulmonary disease, congestive heart failure, respiratory system
    Drug Name
    MEDI-557
    Study Name
    CD-ID-MEDI-557-1089
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of MEDI-557 in Healthy Adults Intranasally Challenged with Respiratory Syncytial Virus (RSV)
    Study Id
    CD-ID-MEDI-557-1090
    Disease
    respiratory syncytial virus infection
    Drug Name
    MEDI-557
    Study Name
    CD-ID-MEDI-557-1090
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase 2 Exploratory Study of Mavrilimumab versus Anti-Tumor Necrosis Factor in Subjects with Rheumatoid Arthritis
    Study Id
    CD-IA-CAM-3001-1107
    Disease
    rheumatoid arthritis
    Drug Name
    CAM-3001
    Study Name
    CD-IA-CAM-3001-1107
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013